Parkinson's disease patients and advocates are marking Friday as the start of a new era for treatment of the illness as a ...

Medtronic received Food and Drug Administration approval for the BrainSense Adaptive deep brain stimulation (DBS) device for people with Parkinson’s disease, a movement disorder of the nervous ...

The Italian neuromodulation startup Newronika has secured a European approval for its closed-loop, adaptive implant for ...

After a twitching pinky finger led to a diagnosis of young-onset Parkinson’s disease, Keith Krehbiel, then 42, stopped at a bookstore on the way home to learn more about the progressive neurological ...

With more than 40,000 DBS patients served worldwide with Medtronic Percept™ devices, BrainSense™ Adaptive DBS presents the largest commercial launch (by several magnitudes) of BCI technology ...

Current FDA approval of this adaptive system is for the treatment of Parkinson’s only, not essential tremor, dystonia (a ...

March 18 (Reuters) - The U.S. Food and Drug Administration on Tuesday classified the recall of Medtronic's (MDT.N), opens new tab embolization device as "most serious", following reports of the ...

Bengaluru: The U.S. Food and Drug Administration on Tuesday classified the recall of Medtronic's embolization device as "most serious", following reports of the deaths of four patients.

Medtronic has recalled certain Pipeline Vantage Embolization Devices with Shield Technology due to an increased risk of incomplete wall apposition and braid deformation, which could lead to stroke ...